Validation and Sensitivity Analysis of the COVID-19 Transmission Model Simulating Counterfactual Infections in Japan

Publication date: Feb 13, 2025

Background: Kayano et al. estimated the potential number of COVID-19 cases and deaths in Japan from February 17 to November 30, 2021, in a counterfactual scenario where no vaccination was implemented. Their model predicted 63.3 million cases and 364,000 deaths, with a claimed 95% confidence interval of less than 1% of the estimated values. Objective: To validate the transmission model used by Kayano et al. by simulating infection counts in Japan during 2020 and assessing the impact of errors in the reproduction number of the Delta variant on infection count estimates in the counterfactual scenario. Methods: We replicated the model used by Kayano et al. to simulate infection dynamics in Japan during 2020. We evaluated the model’s performance by comparing the simulated infection surges with actual data. Additionally, we analyzed the sensitivity of infection count estimates to {+/-}10% errors in the reproduction number of the Delta variant, corresponding to the 95% confidence interval reported in the cited study. Results: The model successfully reproduced the first infection surge in early 2020, but it failed to replicate the second and third infection surges in the summer and winter of 2020. Sensitivity analysis revealed that a {+/-}10% error in the reproduction number led to an estimated infection count error range of -25% to +42%. Conclusion: The results suggest potential limitations in the validity of the counterfactual simulation results presented by Kayano et al., particularly regarding the accuracy of infection count estimates and the confidence interval.

PDF

Concepts Keywords
Corruption Al
June Count
October Counterfactual
Tokyo Covid
Doi
February
Https
Infection
Infections
Japan
Kayano
Medrxiv
Preprint
Simulation
Transmission

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Infections
disease IDO infection
pathway REACTOME Reproduction
disease IDO susceptibility
disease MESH viral load
disease IDO infectivity
disease MESH death
disease MESH infection transmission
drug DRUGBANK Coenzyme M
disease MESH Emergencies
disease IDO cell
disease MESH Hospital Infection

Download Document

(Visited 1 times, 1 visits today)